Yellow fever other feverish illnesses such as malaria. Other viral hemorrhagic fevers, such as Ebola virus, Lassa virus, Marburg virus, and Junin virus, must be excluded as the cause. Personal prevention of yellow fever includes vaccination and avoidance of mosquito bites in areas where yellow fever is endemic. Institutional measures for prevention of yellow fever include vaccination programmes and measures of controlling mosquitoes. Programmes for distribution of mosquito nets for use in homes are providing reductions in cases of both malaria and yellow fever. Use of EPA-registered insect repellent is recommended when outdoors. Exposure for even a short time is enough for
Bas-Congo virus days after the girl's death. This indicates human-to-human transmission of BASV through body fluids and close contact; transmission through aerosol would most likely result in more cases. A fourth person directly caring for the nurse developed antibodies against BASV but remained asymptomatic. Bas-Congo virus The Bas-Congo virus (BASV), named after the former DRC province of Bas-Congo (now Kongo Central), in which it was first discovered, is a novel rhabdovirus associated with a small outbreak of hemorrhagic fever in Mangala village in 2009. The disease is characterized by a fulminant course and can be fatal. In the 2009 outbreak, two out